This work is licensed under the Creative Commons Attribution 4.0 International License.
Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782–793. doi:10.1001/jama.2020.12839WiersingaWJRhodesAChengACet alPathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A ReviewJAMA20203248782–79310.1001/jama.2020.12839Open DOISearch in Google Scholar
National Institutes of Health. Covid-19 Treatment Guidelines. https://www.covid19treatmentguidelines.nih.gov/whatsnew/National Institutes of HealthCovid-19 Treatment Guidelineshttps://www.covid19treatmentguidelines.nih.gov/whatsnew/Search in Google Scholar
Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. European Respiratory Journal. 2020; 55(5): 2001009. https://doi.org/10.1183/13993003.01009-2020HalpinDMGSinghDHadfieldRMInhaled corticosteroids and COVID-19: a systematic review and clinical perspectiveEuropean Respiratory Journal20205552001009doi.org/10.1183/13993003.01009-2020Open DOISearch in Google Scholar
Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med. 2020;201(11):1319-1320. doi:10.1164/rccm.202004-1076EDTobinMJBasing respiratory management of COVID-19 on physiological principlesAm J Respir Crit Care Med2020201111319–132010.1164/rccm.202004-1076EDOpen DOISearch in Google Scholar
Nevitt SJ, Jones AP, Howard J. Hydroxyurea (hydroxycarbamide) for sickle cell disease. Cochrane Database of Systematic Review. 2017; 4: CD002202. doi: 10.1002/14651858.CD002202.pun2.NevittSJJonesAPHowardJHydroxyurea (hydroxycarbamide) for sickle cell diseaseCochrane Database of Systematic Review20174CD00220210.1002/14651858.CD002202.pun2Open DOISearch in Google Scholar
Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infectious Disease. 2020;20(4):425434. doi:10.1016/S1473-3099(20)30086-4ShiHHanXJiangNet alRadiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Lancet Infectious Disease202020442543410.1016/S1473-3099(20)30086-4Open DOISearch in Google Scholar
Dhont S, Derom E, Van Braeckel E, et al. The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respiratory Research. 2020; 21( 198). https://doi.org/10.1186/s12931-020-01462-5DhontSDeromEVanBraeckel Eet alThe pathophysiology of ‘happy’ hypoxemia in COVID-19Respiratory Research202021198https://doi.org/10.1186/s12931-020-01462-510.1186/s12931-020-01462-5738571732723327Search in Google Scholar
Khandros E, Huang P, Peslak SA, et al. Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts. Blood. 2020;135(22):1957-1968. doi:10.1182/blood.2020005058KhandrosEHuangPPeslakSAet alUnderstanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblastsBlood2020135221957–196810.1182/blood.2020005058725635832268371Open DOISearch in Google Scholar
Panepinto JA, Brandow AM, Singh A. Secure-SCD Registry. Medical College of Wisconsin. (October 2020) https://covidsicklecell.org/PanepintoJABrandowAMSinghASecure-SCD RegistryMedical College of WisconsinOctober2020https://covidsicklecell.org/Search in Google Scholar
Ramachandran P, Perisetti A, Kathirvelu B, et al. Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience. eJHaem. 2020;1–7. https://doi.org/10.1002/jha2.87RamachandranPPerisettiAKathirveluBet alLow morbidity and mortality with COVID-19 in sickle cell disease: A single center experienceeJHaem20201–7https://doi.org/10.1002/jha2.8710.1002/jha2.87Search in Google Scholar